Fig. 6From: Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer’s diseaseCorrelation between the IL-1β level in plasma and CSF in patients with aMCI and AD. a Correlation of IL-1β level in plasma and CSF in patients with aMCI. b Correlation of IL-1β level in plasma and CSF in patients with AD. n = 33 for aMCI, n = 33 for AD. The correlation was established by calculating correlation coefficientsBack to article page